NCT06108232 2026-04-07Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular LymphomaM.D. Anderson Cancer CenterPhase 2 Active not recruiting33 enrolled
NCT03322865 2025-04-04Obinutuzumab in Marginal Zone LymphomaUniversity of UlmPhase 2 Active not recruiting56 enrolled